ArticleDiabetes, obesity & metabolism2026
Quality of Diabetes Care Among Older Adults in Germany-Results of the Study on Health of Older People 2022/2023 Compared With Previous National Health Surveys.
Article in Diabetes, obesity & metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Quality of Diabetes Care Among Older Adults in Germany-Results of the Study on Health of Older People 2022/2023 Compared With Previous National Health Surveys.Diabetes, obesity & metabolism · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
aimsThe study aims (1) to evaluate the quality of diabetes care considering guideline-recommended medical therapies, cardiometabolic factors, and self-management of health behaviours among older adults with diabetes in Germany, and (2) to examine time trends. MATERIALS AND
methodsPeople aged 66 years and older with diabetes were identified from the examination part of the German national Study on Health of Older People (Gesundheit65+) in 2022/2023. Diabetes care indicators included physical exercise, non-smoking, non-obesity, blood pressure (BP) control, guideline-based medication use for statins, ACEI/ARB, GLP-1RA/SGLT2i, and aspirin. Temporal trends were examined in a subgroup aged 66-79 years using national health survey data from 1997 to 1999 and 2008 to 2010.
resultsOf 292 older adults with diabetes in Gesundheit65+, 90.6% were non-smokers, 69.6% were non-obese, 74.2% achieved BP control, and 45.5% engaged in physical exercise. Overall, 73.6% reported use of antidiabetics, with 24.3% treated by mono-metformin therapy, 16.9% with insulin (alone or in combination), and 32.4% by other glucose-lowering medication. Guideline-recommended medication use was 65.7% for statins overall and 88.4% for ACEI/ARB among individuals with hypertension. Among individuals with cardiovascular disease, it was 36.8% for GLP-1 RA/SGLT2i and 55.4% for aspirin. Trend analysis in 66- to 79-year-olds showed a decrease in insulin use and improvements regarding physical exercise, non-obesity, BP control and guideline-based medications.
conclusionsIn Germany, most older adults with diabetes meet targets of non-smoking, non-obesity and BP control. Use of novel glucose-lowering medications with cardiorenal benefits is low. Despite improvements over time, guideline-based medication use should be further improved.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.